X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Pharmacovigilance and Drug Safety Software Companies

This report lists the top Pharmacovigilance and Drug Safety Software companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Pharmacovigilance and Drug Safety Software industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Pharmacovigilance and Drug Safety Software Top Companies

  1. Ennov Solutions Inc.

  2. Extedo GmbH

  3. United BioSource Corporation

  4. Ab Cube

  5. ArisGlobal

*Disclaimer: Top companies sorted in no particular order

 Pharmacovigilance and Drug Safety Software Market Major Players

Pharmacovigilance and Drug Safety Software Market Concentration

Pharmacovigilance and Drug Safety Software Market Concentration

Pharmacovigilance and Drug Safety Software Company List

                              • Ab Cube

                              • ArisGlobal

                              • Ennov Solutions Inc.

                              • Extedo GmbH

                              • Anju Software, Inc.

                              • Oracle Corporation

                              • Sarjen Systems Pvt Ltd

                              • Sparta Systems Inc.

                              • United BioSource Corporation

                              • Veeva Systems


                          Specific to Pharmacovigilance and Drug Safety Software Market
                          Need More Details On Market Players And Competitors?
                          Download PDF

                          Pharmacovigilance and Drug Safety Software Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)